EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-cont... by Rice, Andrew S C, Prof, Dworkin, Robert H, Prof, McCarthy, Tom D, PhD, Anand, Praveen, Prof, Bountra, Chas, Prof, McCloud, Philip I, PhD, Hill, Julie, MSc, Cutter, Gary, Prof, Kitson, Geoff, BM BS, Desem, Nuket, MBA, Raff, Milton, FCA [SA]

Get full text